• LAST PRICE
    1.0200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.9701/ 3
  • Ask / Lots
    1.0200/ 50
  • Open / Previous Close
    --- / 1.0200
  • Day Range
    ---
  • 52 Week Range
    Low 0.6300
    High 1.7600
  • Volume
    110
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.9903
TimeVolumeACHL
09:32 ET10000.975
09:36 ET8900.977
09:45 ET30450.9764
10:10 ET21310.9764
10:12 ET1000.9903
10:14 ET1000.9903
10:24 ET1000.9903
10:26 ET17420.98
10:33 ET1000.9903
10:39 ET31000.9851
10:42 ET1000.9812
10:48 ET1001
10:55 ET2000.9979
11:09 ET30470.993
11:11 ET2000.99307
11:13 ET19000.99305
11:24 ET10000.993
11:40 ET4000.99
12:12 ET3980.9902
12:18 ET1000.9902
12:27 ET27000.9882
12:30 ET1000.9931
12:41 ET1001
01:12 ET1001
01:19 ET2200.9857
01:21 ET6000.9856
01:26 ET1001
01:30 ET1700.987
01:32 ET189750.987
01:33 ET5500.987
01:42 ET1011
01:44 ET1001
01:46 ET123450.9985
01:57 ET1001.01
02:06 ET1001.01
02:11 ET16591.01
02:15 ET80001.01
02:20 ET1001.02
02:24 ET1001.02
02:27 ET1001.02
02:29 ET100001
02:33 ET1001.01
02:47 ET1001.02
02:51 ET1001.02
02:56 ET1001.02
02:58 ET1001.02
03:02 ET1001.02
03:05 ET1001.02
03:09 ET1001.02
03:12 ET5001.02
03:16 ET1001.02
03:20 ET1001.02
03:21 ET6161.02
03:25 ET1001.02
03:27 ET4011.02
03:34 ET15811.01
03:36 ET1001.02
03:38 ET8191.02
03:39 ET1001.02
03:41 ET1001.02
03:43 ET1001.02
03:45 ET1001.02
03:48 ET2001.02
03:50 ET1001.02
03:52 ET5081.02
03:54 ET2001.02
03:56 ET2001.02
03:57 ET7011.01
03:59 ET39011.02
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesACHL
Achilles Therapeutics PLC
41.9M
-0.6x
---
United StatesVTVT
vTv Therapeutics Inc
42.7M
-2.1x
---
United StatesHSTC
HST Global Inc
43.2M
-49.8x
---
United StatesRVPH
Reviva Pharmaceuticals Holdings, Inc.
40.4M
-0.9x
---
United StatesESLA
Estrella Immunopharma Inc
40.2M
-0.6x
---
United StatesAEON
Aeon Biopharma Inc
43.9M
-0.1x
---
As of 2024-10-04

Company Information

Achilles Therapeutics plc is a United Kingdom-based clinical-stage immuno-oncology biopharmaceutical company. The Company is engaged in developing precision T cell therapies to treat multiple types of solid tumors. Its lead product is a precision tumor-derived T cell therapy targeting clonal cancer neoantigens. Its pipeline includes Chiron: Advanced Non-Small Cell Lung Cancer, Thetis: Melanoma (Monotherapy), Thetis: Melanoma (PD-1 Combination), and other indications. It is focused on advancing cancer therapies through its work in the field of tumor evolution. Its platform enables to identify mutations formed early in the development of a cancer that give rise to antigens that are expressed by all of a patient's cancer cells but are absent from healthy tissue. It refers to this class of solid tumor targets as clonal neoantigens. To identify clonal neoantigens in a patient, it has developed a bioinformatic platform called PELEUS.

Contact Information

Headquarters
245 Hammersmith Road, Gunnels Wood RoadLONDON, United Kingdom W6 8PW
Phone
208-154-4600
Fax
---

Executives

Non-Executive Independent Chairman of the Board
Edwin Moses
Chief Executive Officer, Executive Director
Iraj Leo Kiryakos Keverian Ali
Chief Financial Officer
Robert Coutts
Chief Scientific Officer
Sergio Quezada
Chief Medical Officer
Karl Peggs

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$41.9M
Revenue (TTM)
$0.00
Shares Outstanding
41.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.34
EPS
$-1.59
Book Value
$3.47
P/E Ratio
-0.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.